| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | KDM3A IL31RA ARID3A PPRC1 NACA NSD1 BCL11A DCC MED19 PIAS3 TLE2 DOT1L AJUBA TOX2 HCFC1 TRIM37 | 4.54e-05 | 562 | 178 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD2 ARHGEF28 TRIO RALGPS2 RAPGEF1 ARHGAP39 SIPA1 ARHGEF17 ASAP1 ARHGAP31 RALGPS1 ARHGEF1 KNDC1 ARHGAP33 | 1.88e-04 | 507 | 178 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD2 ARHGEF28 TRIO RALGPS2 RAPGEF1 ARHGAP39 SIPA1 ARHGEF17 ASAP1 ARHGAP31 RALGPS1 ARHGEF1 KNDC1 ARHGAP33 | 1.88e-04 | 507 | 178 | 14 | GO:0030695 |
| Domain | PDZ | 6.27e-05 | 141 | 178 | 8 | PF00595 | |
| Domain | PDZ | 8.81e-05 | 148 | 178 | 8 | SM00228 | |
| Domain | - | 9.68e-05 | 150 | 178 | 8 | 2.30.42.10 | |
| Domain | RASGEF | 1.01e-04 | 26 | 178 | 4 | PS00720 | |
| Domain | PDZ | 1.01e-04 | 151 | 178 | 8 | PS50106 | |
| Domain | PDZ | 1.06e-04 | 152 | 178 | 8 | IPR001478 | |
| Domain | RASGEF_CAT | 1.57e-04 | 29 | 178 | 4 | PS50009 | |
| Domain | RasGEF | 1.80e-04 | 30 | 178 | 4 | PF00617 | |
| Domain | - | 1.80e-04 | 30 | 178 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.80e-04 | 30 | 178 | 4 | IPR001895 | |
| Domain | RasGEF | 1.80e-04 | 30 | 178 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 1.80e-04 | 30 | 178 | 4 | IPR023578 | |
| Domain | PH_dom-like | RGPD2 ARHGEF28 TRIO RALGPS2 IRS1 ARHGEF17 ASAP1 PHLDB1 CMIP RALGPS1 ARHGEF1 TLN1 FRMPD3 | 2.32e-04 | 426 | 178 | 13 | IPR011993 |
| Domain | ZnF_DBF | 2.69e-04 | 3 | 178 | 2 | SM00586 | |
| Domain | ZF_DBF4 | 2.69e-04 | 3 | 178 | 2 | PS51265 | |
| Domain | Znf_DBF | 2.69e-04 | 3 | 178 | 2 | IPR006572 | |
| Domain | REKLES | 2.69e-04 | 3 | 178 | 2 | PS51486 | |
| Domain | REKLES_domain | 2.69e-04 | 3 | 178 | 2 | IPR023334 | |
| Domain | muHD | 2.69e-04 | 3 | 178 | 2 | PF10291 | |
| Domain | zf-DBF | 2.69e-04 | 3 | 178 | 2 | PF07535 | |
| Domain | Muniscin_C | 2.69e-04 | 3 | 178 | 2 | IPR018808 | |
| Domain | Post-SET_dom | 4.35e-04 | 16 | 178 | 3 | IPR003616 | |
| Domain | PostSET | 4.35e-04 | 16 | 178 | 3 | SM00508 | |
| Domain | POST_SET | 4.35e-04 | 16 | 178 | 3 | PS50868 | |
| Domain | AWS | 8.86e-04 | 5 | 178 | 2 | SM00570 | |
| Domain | AWS | 8.86e-04 | 5 | 178 | 2 | PS51215 | |
| Domain | AWS_dom | 8.86e-04 | 5 | 178 | 2 | IPR006560 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SLK ARHGEF28 TRIO DSP RAPGEF1 ARHGAP39 ARHGEF17 ARHGAP31 ARHGEF1 NISCH FAM135A PHIP ARHGAP33 | 7.08e-05 | 439 | 117 | 13 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SLK ARHGEF28 TRIO DSP RAPGEF1 ARHGAP39 ARHGEF17 ARHGAP31 ARHGEF1 NISCH FAM135A PHIP ARHGAP33 | 9.08e-05 | 450 | 117 | 13 | M27078 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.04e-04 | 175 | 117 | 8 | MM14941 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.79e-04 | 142 | 117 | 7 | MM15576 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.02e-04 | 301 | 117 | 10 | MM15983 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.41e-04 | 149 | 117 | 7 | M41805 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.66e-04 | 69 | 117 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.85e-04 | 70 | 117 | 5 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.85e-04 | 70 | 117 | 5 | MM15597 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.69e-04 | 74 | 117 | 5 | M41807 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG ARID3A EP400 TRIO LAT2 PPRC1 TMEM94 INTS1 PSMB10 NSD1 RAPGEF1 IRS1 KANSL3 PHLDB1 ZC3H11A C2CD3 ZBED4 RALGPS1 NISCH TTLL4 TLN1 PKD1 NAV2 ZFYVE26 UBE3C DOT1L HECTD1 HCFC1 ARHGAP33 AHNAK2 | 3.07e-13 | 1105 | 187 | 30 | 35748872 |
| Pubmed | SLK EP400 PPRC1 TMEM94 HEATR5A BCL11A ARHGEF17 VIRMA ASAP1 PHLDB1 ZC3H11A ZBED4 PHF3 NISCH TLN1 UBE3C CAMSAP2 PDZD2 | 1.01e-11 | 407 | 187 | 18 | 12693553 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3A SYNRG ARID3A EP400 TACC2 CTTNBP2NL ARID3B KANSL3 ZC3H11A PIAS3 SLF2 PHF3 TLN1 SUGP1 MTRR HCFC1 CCDC102A AHNAK2 | 4.19e-11 | 444 | 187 | 18 | 34795231 |
| Pubmed | KDM3A SYNRG SLK CEP85 EP400 TCOF1 DSP PDLIM7 NSD1 ARID3B ZC3H11A PHF3 TLN1 AMOTL1 DOT1L HCFC1 RSBN1L CUX1 | 1.26e-09 | 549 | 187 | 18 | 38280479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG HIVEP1 ARHGEF28 TRIO DSP MBD1 RALGPS2 IRS1 ARHGEF17 VIRMA E2F8 PHLDB1 C2CD3 SLF2 PHF3 ARHGEF1 NAV2 CAMSAP2 HECTD1 CCDC102A AHNAK2 | 9.51e-09 | 861 | 187 | 21 | 36931259 |
| Pubmed | TBRG4 TCOF1 TACC2 FCHO2 IPO4 POLR1G CTTNBP2NL PDCD4 DFFA ZC3H11A NFATC2IP EHMT2 PHF3 NAV2 BAG6 HCFC1 | 1.66e-08 | 503 | 187 | 16 | 16964243 | |
| Pubmed | HIVEP1 DSP SREBF2 RAPGEF1 EVPL NCKAP5 ASAP1 TGFB1 KIAA1549L PIAS3 ARHGAP31 ARHGEF1 NAV2 CUX1 ARHGAP33 | 6.99e-08 | 486 | 187 | 15 | 20936779 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG HIVEP1 CEP85 EP400 TCOF1 DSP TACC2 ZDBF2 IPO4 KANSL3 NFATC2IP SLF2 TSEN34 DOT1L FAM135A TRIM37 | 1.40e-07 | 588 | 187 | 16 | 38580884 |
| Pubmed | HIVEP1 EP400 RFX5 ARID3B KANSL3 NFATC2IP EHMT2 PHF3 SUGP1 HCFC1 CUX1 | 2.55e-07 | 268 | 187 | 11 | 33640491 | |
| Pubmed | KDM3A CEP85 TRIO TCOF1 DSP PPRC1 MBD1 ASH1L AIRE NCKAP5 GRIN2B CMYA5 UBASH3A RFX5 PIAS3 EHMT2 SLF2 NISCH PKD1 HECTD1 TRIM37 RSBN1L CUX1 | 4.85e-07 | 1285 | 187 | 23 | 35914814 | |
| Pubmed | 6.44e-07 | 57 | 187 | 6 | 18022353 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | CEP85 DSP RFX5 ZC3H11A C2CD3 ARHGAP31 CAMSAP2 TRIM37 CCDC102A | 7.54e-07 | 184 | 187 | 9 | 32908313 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A HIVEP1 ARID3A ZNF280C INTS1 NSD1 RFX5 ARID3B NFATC2IP EHMT2 PHF3 DOT1L HCFC1 PHIP CUX1 | 1.19e-06 | 608 | 187 | 15 | 36089195 |
| Pubmed | RGPD2 SLK SGIP1 TRIO TCOF1 NHSL2 NSD1 BCL11A GRIN2B ARHGAP39 SIPA1 IPO4 VIRMA NLGN3 EHMT2 NISCH FRMPD3 CAMSAP2 CUX1 | 1.25e-06 | 963 | 187 | 19 | 28671696 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.41e-06 | 256 | 187 | 10 | 33397691 | |
| Pubmed | PPRC1 ASH1L RALGPS2 SREBF2 NSD1 TACC2 NCSTN FCHO2 TUB E2F8 ASAP1 NLGN3 ZC3H11A ARHGEF1 VCAN TTLL4 DOT1L FAM135A TRIM37 PARP12 | 1.81e-06 | 1084 | 187 | 20 | 11544199 | |
| Pubmed | 1.91e-06 | 153 | 187 | 8 | 10718198 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TUT4 HIVEP1 DBF4B MBD1 RABAC1 TACC2 BCL11A SIPA1 NLGN3 PHLDB1 KIAA1549L PIAS3 GRIP2 PYCR2 | 2.34e-06 | 560 | 187 | 14 | 21653829 |
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 3.02e-06 | 6 | 187 | 3 | 24019522 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG SLK EP400 TCOF1 DSP ZNF280C NACA TACC2 PDCD4 ZC3H11A PDLIM3 TLN1 SUGP1 CAMSAP2 HCFC1 RSBN1L PARP12 AHNAK2 | 3.36e-06 | 934 | 187 | 18 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 EP400 DSP ZNF280C NSD1 ZDBF2 RFX5 ARID3B ZC3H11A MED19 SLF2 PHF3 SUGP1 ZNF830 HCFC1 PHIP RSBN1L CUX1 | 4.49e-06 | 954 | 187 | 18 | 36373674 |
| Pubmed | KDM3A TBRG4 EP400 ZNF280C NACA NCSTN CTTNBP2NL KANSL3 ARHGAP31 RALGPS1 TTLL4 NAV2 CACNA1G | 6.53e-06 | 529 | 187 | 13 | 14621295 | |
| Pubmed | 6.70e-06 | 49 | 187 | 5 | 34368113 | ||
| Pubmed | TCOF1 NACA ARHGAP39 POLR1G CTTNBP2NL AMER2 PHF3 ZNF830 CAMSAP2 | 8.14e-06 | 246 | 187 | 9 | 15345747 | |
| Pubmed | KLF11 HIVEP1 ARID3A MLX MBD1 ZNF280C ASH1L AIRE RFX5 ARID3B ZBED4 PIAS3 ZNF830 AJUBA CUX1 PARP12 | 8.61e-06 | 808 | 187 | 16 | 20412781 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | SYNRG TBRG4 TUT4 CEP85 PDLIM7 PDLIM3 AMOTL1 FER MTRR CCDC102A | 1.07e-05 | 322 | 187 | 10 | 39098523 |
| Pubmed | TUT4 EP400 TRIO TMEM94 NACA ZDBF2 ARID3B PHF3 TTLL4 AMOTL1 SUGP1 UBE3C HECTD1 HCFC1 RSBN1L | 1.13e-05 | 733 | 187 | 15 | 34672954 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.50e-05 | 146 | 187 | 7 | 23892456 | |
| Pubmed | TUT4 EP400 TCOF1 DSP PPRC1 DBF4B NACA ADGB PHLDB1 NDC1 EHMT2 TNFRSF8 CACNA1G GRIP2 MOV10 | 1.57e-05 | 754 | 187 | 15 | 35906200 | |
| Pubmed | Modulation of gene expression in the preimplantation mouse embryo by TGF-alpha and TGF-beta. | 1.79e-05 | 10 | 187 | 3 | 7654366 | |
| Pubmed | EP400 PDLIM7 MBD1 NACA INTS1 NSD1 ARHGAP39 IPO4 POLR1G VIRMA CTTNBP2NL BDH1 ZC3H11A MED19 MICALL2 EHMT2 PHF3 TLN1 GORAB CAMSAP2 RSBN1L MOV10 | 2.00e-05 | 1497 | 187 | 22 | 31527615 | |
| Pubmed | 2.40e-05 | 282 | 187 | 9 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.47e-05 | 283 | 187 | 9 | 30585729 | |
| Pubmed | 2.79e-05 | 360 | 187 | 10 | 33111431 | ||
| Pubmed | KLF11 HIVEP1 LAT2 PDLIM7 MBD1 KIAA1549L CACNA1G GRIP2 PYCR2 AJUBA CAMSAP2 BAG6 TRIM37 | 2.81e-05 | 608 | 187 | 13 | 16713569 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 17114344 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 25071150 | ||
| Pubmed | G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. | 2.88e-05 | 2 | 187 | 2 | 18535151 | |
| Pubmed | TGF-β Induces Endometriotic Progression via a Noncanonical, KLF11-Mediated Mechanism. | 2.88e-05 | 2 | 187 | 2 | 27384304 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19124737 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 2.88e-05 | 2 | 187 | 2 | 33526815 | |
| Pubmed | A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. | 2.88e-05 | 2 | 187 | 2 | 15983060 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 11006284 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 27785750 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 2.88e-05 | 2 | 187 | 2 | 36449053 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 8543152 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 23769972 | ||
| Pubmed | ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells. | 2.88e-05 | 2 | 187 | 2 | 32061921 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 37814859 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 37259724 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19617579 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19616629 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 12193717 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 2.88e-05 | 2 | 187 | 2 | 24096970 | |
| Pubmed | 2.91e-05 | 222 | 187 | 8 | 37071664 | ||
| Pubmed | IL16 SLK SGIP1 TRIO DSP BCL11A GRIN2B ARHGAP39 SIPA1 ARHGEF17 VIRMA ASAP1 NLGN3 PHLDB1 ARHGEF1 NISCH VCAN TLN1 KNDC1 PYCR2 CAMSAP2 | 3.19e-05 | 1431 | 187 | 21 | 37142655 | |
| Pubmed | 3.67e-05 | 114 | 187 | 6 | 21150319 | ||
| Pubmed | 4.05e-05 | 116 | 187 | 6 | 30804394 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | TBRG4 TUT4 HIVEP1 ARHGEF28 MLX DBF4B MBD1 ZNF280C SREBF2 C11orf24 IPO4 RFX5 ARHGEF1 TLN1 PKD1 TSEN34 | 4.42e-05 | 925 | 187 | 16 | 28986522 |
| Pubmed | RGPD2 SYNRG TUT4 SGIP1 TRIO DSP NACA TACC2 ZDBF2 GRIN2B ARHGAP39 KCNB2 BDH1 ASAP1 AMER2 KNDC1 PYCR2 CAMSAP2 | 4.73e-05 | 1139 | 187 | 18 | 36417873 | |
| Pubmed | Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster. | 5.33e-05 | 14 | 187 | 3 | 10941842 | |
| Pubmed | CEP85 EP400 TRIO ZNF280C NACA FCHO2 CTTNBP2NL ASAP1 KANSL3 PHF3 CUX1 | 5.48e-05 | 472 | 187 | 11 | 38943005 | |
| Pubmed | TCOF1 DSP INTS1 NSD1 IPO4 VIRMA ZC3H11A PHF3 TLN1 HECTD1 HCFC1 PHIP MOV10 | 5.83e-05 | 653 | 187 | 13 | 22586326 | |
| Pubmed | 6.14e-05 | 182 | 187 | 7 | 15102471 | ||
| Pubmed | 6.71e-05 | 322 | 187 | 9 | 26514267 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MLX EP400 TCOF1 DSP MBD1 INTS1 NSD1 POLR1G RFX5 KANSL3 ZC3H11A NDC1 TBRG1 ZBED4 EHMT2 SLF2 PHF3 HCFC1 CUX1 | 7.68e-05 | 1294 | 187 | 19 | 30804502 |
| Pubmed | 7.91e-05 | 329 | 187 | 9 | 17474147 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A SYNRG HIVEP1 EP400 TCOF1 DSP ARHGAP39 POLR1G VIRMA CTTNBP2NL KANSL3 ZC3H11A PHF3 BAG6 | 8.40e-05 | 774 | 187 | 14 | 15302935 |
| Pubmed | 8.47e-05 | 332 | 187 | 9 | 37433992 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 8.47e-05 | 332 | 187 | 9 | 32786267 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 24071006 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 10838570 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 21465620 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 22353043 | ||
| Pubmed | Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model. | 8.60e-05 | 3 | 187 | 2 | 28701314 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 29186691 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 29463719 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 18189266 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 9412476 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 11018022 | ||
| Pubmed | Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. | 8.60e-05 | 3 | 187 | 2 | 9651377 | |
| Pubmed | Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. | 8.60e-05 | 3 | 187 | 2 | 1346270 | |
| Pubmed | Uridylation by TUT4/7 Restricts Retrotransposition of Human LINE-1s. | 8.60e-05 | 3 | 187 | 2 | 30122351 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 33649863 | ||
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 15269344 | ||
| Pubmed | Cellular growth inhibition by TGF-beta1 involves IRS proteins. | 8.60e-05 | 3 | 187 | 2 | 15135063 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 22373577 | ||
| Pubmed | CRKL, AIFM3, AIF, BCL2, and UBASH3A during Human Kidney Development. | 8.60e-05 | 3 | 187 | 2 | 34502088 | |
| Pubmed | DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. | 8.60e-05 | 3 | 187 | 2 | 34551297 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 18343819 | ||
| Pubmed | TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells. | 8.60e-05 | 3 | 187 | 2 | 37461061 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 24464130 | ||
| Pubmed | TGF-β1 promotes osteosarcoma cell migration and invasion through the miR-143-versican pathway. | 8.60e-05 | 3 | 187 | 2 | 25562163 | |
| Pubmed | 8.60e-05 | 3 | 187 | 2 | 21199920 | ||
| Pubmed | 8.81e-05 | 83 | 187 | 5 | 28794006 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 9.05e-05 | 134 | 187 | 6 | 25452129 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MARS2 SLK TBRG4 HIVEP1 TRIO TCOF1 DSP ZNF280C NACA IPO4 CMYA5 DFFA ZC3H11A NDC1 TLN1 UBE3C PYCR2 BAG6 HCFC1 PHIP | 9.13e-05 | 1425 | 187 | 20 | 30948266 |
| Pubmed | 1.01e-04 | 197 | 187 | 7 | 36604605 | ||
| Pubmed | 1.04e-04 | 86 | 187 | 5 | 37253089 | ||
| Pubmed | MARS2 CEP85 PDLIM7 NACA RABAC1 NCSTN TGFB1 EFNB1 PDLIM3 GORAB SUGP1 ZNF830 PYCR2 FAM135A RSBN1L MOV10 | 1.19e-04 | 1007 | 187 | 16 | 34597346 | |
| Interaction | H3C1 interactions | ARID3A DSP ZNF280C NACA INTS1 ASH1L NSD1 AIRE IPO4 POLR1G RFX5 VIRMA PDCD4 PIEZO2 MICALL2 EHMT2 PHF3 NAV2 ZNF830 PHIP RSBN1L CUX1 MOV10 PDZD2 | 2.08e-06 | 901 | 182 | 24 | int:H3C1 |
| Interaction | PHLPP1 interactions | SLK TCOF1 DSP PDLIM7 NACA ZDBF2 FCHO2 CMYA5 VIRMA EFNB1 TLN1 SUGP1 HCFC1 AHNAK2 | 2.13e-06 | 333 | 182 | 14 | int:PHLPP1 |
| Interaction | TERF2IP interactions | KDM3A HIVEP1 ARID3A EP400 ZNF280C INTS1 NSD1 RFX5 PDCD4 KANSL3 ZC3H11A NFATC2IP PHF3 SUGP1 ZNF830 HECTD1 HCFC1 CUX1 | 2.81e-06 | 552 | 182 | 18 | int:TERF2IP |
| Interaction | TOP3B interactions | SYNRG ARID3A EP400 TRIO LAT2 PPRC1 TMEM94 INTS1 PSMB10 NSD1 RAPGEF1 IRS1 IPO4 KANSL3 PHLDB1 ZC3H11A C2CD3 ZBED4 RALGPS1 NISCH TTLL4 TLN1 PKD1 NAV2 ZFYVE26 UBE3C DOT1L HECTD1 HCFC1 ARHGAP33 MOV10 AHNAK2 | 2.87e-06 | 1470 | 182 | 32 | int:TOP3B |
| Interaction | FBXO38 interactions | 6.93e-06 | 145 | 182 | 9 | int:FBXO38 | |
| Interaction | EN1 interactions | 7.09e-06 | 110 | 182 | 8 | int:EN1 | |
| Interaction | AR interactions | KDM3A HIVEP1 EP400 DSP NSD1 IPO4 DCC RFX5 VIRMA ARID3B KANSL3 KDM4D PIAS3 NFATC2IP EHMT2 PHF3 NISCH SUGP1 TSEN34 DOT1L BAG6 HCFC1 CUX1 PARP12 | 1.06e-05 | 992 | 182 | 24 | int:AR |
| Interaction | OTUD7A interactions | 1.37e-05 | 58 | 182 | 6 | int:OTUD7A | |
| Interaction | YWHAG interactions | SYNRG SLK HIVEP1 ARHGEF28 MLX DSP NHSL2 MBD1 RALGPS2 IRS1 SIPA1 ARHGEF17 VIRMA PDCD4 E2F8 PPP1R3D DFFA PHLDB1 C2CD3 PHF3 ARHGEF1 NAV2 CAMSAP2 HECTD1 CCDC102A AHNAK2 | 5.78e-05 | 1248 | 182 | 26 | int:YWHAG |
| Interaction | HNF1B interactions | 5.93e-05 | 190 | 182 | 9 | int:HNF1B | |
| Interaction | MCF2L interactions | 5.94e-05 | 24 | 182 | 4 | int:MCF2L | |
| Interaction | H2BC21 interactions | EP400 ATXN7L1 DBF4B ZNF280C NSD1 AIRE VIRMA PDCD4 KDM4D C2CD3 KIAA1549L EHMT2 PHF3 TLN1 FER PYCR2 HCFC1 PHIP | 6.26e-05 | 696 | 182 | 18 | int:H2BC21 |
| GeneFamily | PDZ domain containing | 4.71e-06 | 152 | 112 | 8 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.61e-05 | 34 | 112 | 4 | 487 | |
| GeneFamily | Zinc fingers DBF-type | 1.14e-04 | 3 | 112 | 2 | 75 | |
| GeneFamily | LIM domain containing | 4.89e-04 | 59 | 112 | 4 | 1218 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.04e-03 | 8 | 112 | 2 | 939 | |
| GeneFamily | Zinc fingers CCCH-type | 1.31e-03 | 35 | 112 | 3 | 73 | |
| GeneFamily | PHD finger proteins | 2.37e-03 | 90 | 112 | 4 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 3.20e-03 | 160 | 112 | 5 | 555 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.67e-03 | 50 | 112 | 3 | 721 | |
| GeneFamily | AT-rich interaction domain containing | 3.79e-03 | 15 | 112 | 2 | 418 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | MARS2 SLK PPRC1 MBD1 ZNF280C C11orf24 TACC2 TTLL4 TMEM65 MTRR | 1.78e-06 | 200 | 186 | 10 | M7791 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | LILRB3 TUT4 MBD1 INTS1 LILRA6 AIRE RAPGEF1 NCSTN ITGAL ARID3B CMIP NFATC2IP FCGRT RALGPS1 NISCH SUGP1 ZFYVE26 HCFC1 CUX1 ARHGAP33 | 7.43e-06 | 905 | 186 | 20 | M40865 |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.38e-05 | 200 | 186 | 9 | M9459 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | ARHGEF28 RAPGEF1 CTTNBP2NL PDCD4 CFAP54 CMIP ARHGAP31 TOX2 FAM135A | 1.02e-07 | 187 | 187 | 9 | 40ffc06a3e3251d9b12da390210d3e045af7537a |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 181 | 187 | 8 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 181 | 187 | 8 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 181 | 187 | 8 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 185 | 187 | 8 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-06 | 193 | 187 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 194 | 187 | 8 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 194 | 187 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.67e-06 | 162 | 187 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 9.05e-06 | 174 | 187 | 7 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.44e-05 | 187 | 187 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 188 | 187 | 7 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.50e-05 | 188 | 187 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-05 | 192 | 187 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 192 | 187 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.82e-05 | 77 | 187 | 5 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.16e-05 | 199 | 187 | 7 | a207b4891881149d4c50721310690fd794157723 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 187 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 187 | 7 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 152 | 187 | 6 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.80e-05 | 164 | 187 | 6 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.04e-05 | 165 | 187 | 6 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 167 | 187 | 6 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 167 | 187 | 6 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.77e-05 | 168 | 187 | 6 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.57e-05 | 171 | 187 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-05 | 173 | 187 | 6 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 176 | 187 | 6 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 176 | 187 | 6 | 9b58734017ceabe81f490dd0b9f3192bc903d455 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.21e-04 | 182 | 187 | 6 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 182 | 187 | 6 | 16186b7a0c33caa48631962381e3ab7e5d166163 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.24e-04 | 183 | 187 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 187 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 187 | 6 | 73ddf9d647d61381bab1e9c0d983736b6d390c15 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.32e-04 | 185 | 187 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 185 | 187 | 6 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Kidney-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 186 | 187 | 6 | b2134215eba77aa6ec1babf5c86be1ebd7818caf | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 186 | 187 | 6 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.40e-04 | 187 | 187 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 188 | 187 | 6 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.48e-04 | 189 | 187 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 187 | 6 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 189 | 187 | 6 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 190 | 187 | 6 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-04 | 190 | 187 | 6 | b8693567e26edb830482a60746bf3632a2bf058c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.52e-04 | 190 | 187 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 190 | 187 | 6 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.52e-04 | 190 | 187 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.52e-04 | 190 | 187 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 191 | 187 | 6 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-04 | 191 | 187 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 192 | 187 | 6 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.61e-04 | 192 | 187 | 6 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.61e-04 | 192 | 187 | 6 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.61e-04 | 192 | 187 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 192 | 187 | 6 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 192 | 187 | 6 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 193 | 187 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 193 | 187 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 193 | 187 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 193 | 187 | 6 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 193 | 187 | 6 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-04 | 194 | 187 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.71e-04 | 194 | 187 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.76e-04 | 195 | 187 | 6 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 195 | 187 | 6 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.76e-04 | 195 | 187 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.76e-04 | 195 | 187 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-04 | 195 | 187 | 6 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.76e-04 | 195 | 187 | 6 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.76e-04 | 195 | 187 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-04 | 196 | 187 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-04 | 196 | 187 | 6 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-04 | 197 | 187 | 6 | b90c8a41e99c87b46be699d03cd49c97a2ad51af | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 1.85e-04 | 197 | 187 | 6 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.85e-04 | 197 | 187 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-04 | 197 | 187 | 6 | 13aec816e21754eac590a12c3a9c795c41108277 | |
| ToppCell | medial-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-04 | 197 | 187 | 6 | 38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-04 | 198 | 187 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 198 | 187 | 6 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 198 | 187 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 198 | 187 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 198 | 187 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 198 | 187 | 6 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | control-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.96e-04 | 199 | 187 | 6 | 31825ba336603fe940dea6022e18ec25af110f4c | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.96e-04 | 199 | 187 | 6 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.01e-04 | 200 | 187 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.01e-04 | 200 | 187 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.01e-04 | 200 | 187 | 6 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-04 | 200 | 187 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.01e-04 | 200 | 187 | 6 | 5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-04 | 200 | 187 | 6 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.01e-04 | 200 | 187 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.01e-04 | 200 | 187 | 6 | 7345cc7dc24b9174541a3e68ecac8c4c092be400 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-04 | 200 | 187 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| Disease | Intellectual Disability | TRIO SPR TMEM94 ASH1L NSD1 BCL11A GRIN2B DCC TSEN34 CACNA1G PYCR2 PHIP | 1.79e-05 | 447 | 177 | 12 | C3714756 |
| Disease | Profound Mental Retardation | 1.99e-04 | 139 | 177 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.99e-04 | 139 | 177 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.99e-04 | 139 | 177 | 6 | C0917816 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.61e-04 | 21 | 177 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | chronic myeloid leukemia (implicated_via_orthology) | 3.54e-04 | 5 | 177 | 2 | DOID:8552 (implicated_via_orthology) | |
| Disease | waist-hip ratio | ATXN7L1 NSD1 ZC3H11B C11orf24 BCL11A GRIN2B SIM1 SIPA1 KCNB2 BDH1 CMIP SCUBE2 NISCH PKD1 DOT1L PHIP RSBN1L CUX1 | 4.38e-04 | 1226 | 177 | 18 | EFO_0004343 |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0802705 | |
| Disease | peripheral neuropathy, response to bortezomib | 5.28e-04 | 6 | 177 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0801767 | |
| Disease | stimulant use measurement | 6.23e-04 | 28 | 177 | 3 | EFO_0600076 | |
| Disease | insulinoma (is_marker_for) | 9.78e-04 | 8 | 177 | 2 | DOID:3892 (is_marker_for) | |
| Disease | cup-to-disc ratio measurement | 1.21e-03 | 430 | 177 | 9 | EFO_0006939 | |
| Disease | body fat distribution | 1.42e-03 | 202 | 177 | 6 | EFO_0004341 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 1.56e-03 | 10 | 177 | 2 | cv:CN043592 | |
| Disease | age at onset, multiple sclerosis | 1.56e-03 | 10 | 177 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | smoking behavior, BMI-adjusted waist-hip ratio | 1.81e-03 | 86 | 177 | 4 | EFO_0004318, EFO_0007788 | |
| Disease | pulse pressure measurement | GDF5-AS1 SGIP1 MBD1 RALGPS2 ZC3H11B HEATR5A SIPA1 TGFB1 CEP68 PIEZO2 MALRD1 KIAA1549L ZFHX4 PKD1 FER DOT1L BAG6 HCFC1 | 1.85e-03 | 1392 | 177 | 18 | EFO_0005763 |
| Disease | brain measurement, neuroimaging measurement | GDF5-AS1 RALGPS2 RABAC1 NCKAP5 DCC RALGPS1 ARHGEF1 VCAN SUGP1 NAV2 | 1.88e-03 | 550 | 177 | 10 | EFO_0004346, EFO_0004464 |
| Disease | Takayasu arteritis | 2.03e-03 | 148 | 177 | 5 | EFO_1001857 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 2.20e-03 | 43 | 177 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.27e-03 | 12 | 177 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | alcohol and nicotine codependence | 2.67e-03 | 13 | 177 | 2 | EFO_0004776 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.67e-03 | 13 | 177 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Genetic chronic primary adrenal insufficiency | 2.67e-03 | 13 | 177 | 2 | Orphanet_101960 | |
| Disease | Connective Tissue Diseases | 2.67e-03 | 13 | 177 | 2 | C0009782 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 2.83e-03 | 47 | 177 | 3 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | body weight | HIVEP1 C16orf82 MBD1 ZNF280C IRS1 SIM1 DCC KCNB2 POLR1G VIRMA MICALL2 PHF3 PKD1 DOT1L ITIH6 PDZD2 | 3.95e-03 | 1261 | 177 | 16 | EFO_0004338 |
| Disease | Hepatomegaly | 4.21e-03 | 54 | 177 | 3 | C0019209 | |
| Disease | susceptibility to common cold measurement | 4.21e-03 | 54 | 177 | 3 | EFO_0008417 | |
| Disease | reticulocyte count | ARHGEF28 ARID3A ZNF280C ASH1L ZC3H11B IRS1 BCL11A SIPA1 MED19 FCGRT NISCH PKD1 CUX1 PDZD2 | 4.33e-03 | 1045 | 177 | 14 | EFO_0007986 |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 4.59e-03 | 17 | 177 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | event free survival time, urinary bladder cancer | 5.72e-03 | 19 | 177 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | leukemia (implicated_via_orthology) | 5.72e-03 | 19 | 177 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | glycoprotein measurement | 5.82e-03 | 119 | 177 | 4 | EFO_0004555 | |
| Disease | Post-Traumatic Osteoporosis | 5.92e-03 | 61 | 177 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 5.92e-03 | 61 | 177 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 5.92e-03 | 61 | 177 | 3 | C0001787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSPRISPATTLRKGD | 376 | Q8IVW6 | |
| SPCSSPVLTKRLLGS | 426 | Q9P2B4 | |
| PVLTKRLLGSSASSP | 431 | Q9P2B4 | |
| NKRLASPVAPGALTT | 2651 | Q96L91 | |
| TITCPLRTPGSLLKD | 591 | Q8N7J2 | |
| TETAGSLKVPAPASR | 756 | Q92888 | |
| ATPSTLLGSRDPDLK | 191 | Q9NR48 | |
| KLLASATPVSGISLP | 2816 | Q96N23 | |
| SASSKLPPALLTTVG | 821 | P13611 | |
| PRGGSLAKVSSSLEP | 216 | Q76N32 | |
| GVSSGLLKTRPSLPA | 581 | Q76N32 | |
| AKAAGARPLTSPESL | 1071 | P46379 | |
| LSRPLSRLPGKTLSA | 6 | Q02338 | |
| KLRLIGSSAPLPCLS | 1081 | Q8N7X0 | |
| SKLLLAPGSSPKTLS | 291 | Q96NN9 | |
| DASKPSSPRGSLLLD | 131 | Q96IF1 | |
| LTQGSVSDLLARPKP | 1156 | P39880 | |
| PASRPKLTSGKLSGI | 466 | Q0JRZ9 | |
| GGPTRLTLPSKSTDA | 636 | Q8IY22 | |
| PNSIALPGTSAKRTK | 36 | Q7L190 | |
| GKTDSSSLRPARSVP | 781 | Q8IY63 | |
| RILLGHATKSFPSSP | 106 | Q96KQ7 | |
| LRSISASKASPPGDL | 306 | O00273 | |
| TPSLSAGVSPKRRAL | 1096 | Q8TEK3 | |
| LTSGVRLKNLSPPTS | 796 | Q96PN6 | |
| PFGSPLLSRSVSLLK | 226 | Q8TF44 | |
| SSSGLHPPKKTLTRS | 1271 | Q9Y485 | |
| KAAQLRPISLPGVSS | 421 | O75071 | |
| GVSPLSAKLEPSGRT | 706 | Q9ULK2 | |
| LTPRGTASPGSQLKA | 146 | O43918 | |
| GSTSLLPEQLLSAPK | 56 | Q5T7V8 | |
| LDKSIGAASPRPQSL | 2361 | Q96L73 | |
| GTRSKSVPELLGTAP | 336 | Q7Z3H0 | |
| LAPRLSSGALKVATL | 351 | P48382 | |
| SSGALKVATLPLSSR | 356 | P48382 | |
| LKRAELPGSSSPLLA | 276 | Q9C0H5 | |
| SSPRLVSSKEDLAGP | 291 | Q5JS13 | |
| SRIAGLAVSLTKPSP | 116 | Q92542 | |
| DRGKPPLSSSRSITL | 426 | Q9Y5F9 | |
| TIAATDRGKPPLSSS | 421 | Q9Y5F8 | |
| DRGKPPLSSSKTITL | 426 | Q9Y5F8 | |
| AGRRGASLLSPKSPT | 36 | Q9UH92 | |
| SKPPSTLLAAGRLSD | 351 | Q8N1W1 | |
| ASPGTRPTLKDLTAT | 526 | Q96PE2 | |
| LAPLSSKVRLSSPSI | 1211 | P51610 | |
| PSDLSAIATTIKPGL | 106 | Q9H4B0 | |
| TASLGLAGKARSPLL | 1381 | P43146 | |
| KRPKLSSTPPLSALG | 76 | Q8N201 | |
| NSLGKSPVATLRIPA | 306 | Q8NI17 | |
| TGEKSPNSPRTLLSL | 31 | A6NMX2 | |
| DSGKALAPKISISPR | 511 | Q9UBK8 | |
| LLLGSPSSLSPFSKR | 621 | Q9H165 | |
| HLGPTLKPTLATRTA | 416 | Q9UIS9 | |
| SLSGRGPTPSLVLSK | 431 | Q8IY33 | |
| GESLTKLRSNLPAPS | 726 | Q9P2D6 | |
| RLKARPSSPGFSVLT | 206 | P55899 | |
| RSGLTVPTSPKGRLL | 86 | Q53EL6 | |
| LSVSSKPPIGRRSSG | 2361 | O15018 | |
| SSSLPPKLLLVSFDG | 21 | Q9Y6X5 | |
| SIGSIISKSPLASPA | 1791 | Q92817 | |
| RLSLQPSSGEAAKPL | 861 | Q14005 | |
| TLQTPAKRPLLAGTT | 466 | Q6B0I6 | |
| VGFPRLASLTLPTKA | 236 | A6NHZ5 | |
| GSPPATRDLLLSSKV | 236 | Q6ZVL6 | |
| ILPSGVSRKPSLLTL | 216 | Q6PI73 | |
| ILPSGVSRKPSLLTL | 216 | O75022 | |
| ARPTRLSLGDPKAST | 856 | P35568 | |
| VPLSISRLTPGGKAA | 26 | Q9NR12 | |
| PVATLSKPSLGDRSK | 191 | Q86Y26 | |
| SKPSVTPSILLALGS | 681 | Q9H0J9 | |
| LGSPVLTKLLTASTP | 536 | Q5VYJ5 | |
| SLSPKPTVGRSLCLT | 11 | Q9NZ94 | |
| ISSLTSAVPRPRGKL | 271 | O14559 | |
| PSGSRPDTVTLRSAK | 621 | O14559 | |
| CTPSPRLALTLKVTG | 1811 | Q9ULT8 | |
| GNSLIAAPLSRSIKP | 26 | Q9NZH7 | |
| LLSLLNSSPGPPTRK | 56 | Q86XA9 | |
| PPGLNRKTSRSTLSL | 6 | Q92953 | |
| SDLSKRPQGLTIKPS | 921 | Q9Y4C1 | |
| KKRGLSDISPSTSLP | 16 | Q4AC94 | |
| SKASASTRPGSLLPA | 571 | A0AVK6 | |
| PSPKKDVLSLSGLSS | 2356 | O43497 | |
| SATTLLPALPKGSRE | 426 | Q8NFT6 | |
| IIRSPKSALGSSALS | 431 | P16591 | |
| VEASLPIALGPKSRS | 1461 | Q5JV73 | |
| PVLASTSKALGPSQL | 46 | Q10981 | |
| LLSPVKPQTLASGAS | 2811 | Q8N3K9 | |
| RLLEAASVSSKGLPS | 2801 | P15924 | |
| SPRLAESPQLSKGSL | 6 | Q96A19 | |
| SKGSLLTILGSPSPE | 16 | Q96A19 | |
| LPLSTGPASRLAAKS | 526 | Q9HC77 | |
| VGPSSSKLPLSGLAE | 111 | Q6P2H3 | |
| RAAALSLSTLASPKG | 276 | P98172 | |
| VTSRLRGKAPALSPS | 226 | Q5U4N7 | |
| GRLAEARASTSSPKP | 56 | A6NJJ6 | |
| STSSAKTALGPRVLP | 881 | Q9ULH1 | |
| SNSGTLLPLKPGSLS | 731 | Q6UXX5 | |
| SKLPGSPLILIASSG | 266 | Q9P2N6 | |
| KLNRIASAESPGSPL | 491 | O14901 | |
| SRGPRASPTKALLST | 251 | Q76NI1 | |
| ASPTKALLSTPVRNG | 256 | Q76NI1 | |
| LPIRALPFSASSSGK | 46 | Q8NAJ2 | |
| TLLPKGRSALPPSSR | 426 | Q6UWV6 | |
| PLLPRKSGSLSETSD | 741 | Q9C0E4 | |
| KGLLPTSVSPRVSLH | 446 | Q9NQ36 | |
| PSSPRAKELAVSALG | 491 | Q8TEX9 | |
| TGVLRSCGTLTLKPP | 776 | Q8TEX9 | |
| GSSLHKLLTLSRTPP | 161 | Q5VV67 | |
| IKGPPVSSLSLASLN | 1281 | Q08AD1 | |
| PRLSAPSTKAVIAGI | 141 | P21452 | |
| SAVAPGPSALDRKVT | 476 | Q969Z0 | |
| ISAASTPLASKLLGP | 471 | Q8WUT4 | |
| LPSRSSRGSKVSPDV | 4161 | P98161 | |
| SLKIEPGTSTPRSAA | 281 | Q86X27 | |
| SLRSLIEKPPILSSS | 126 | A0JLT2 | |
| RGDLSLSLALKTGPT | 161 | Q9GZY6 | |
| LSSRDPPGSLSAKKV | 31 | Q6PCB5 | |
| PGTRTGLLKLLSTVS | 31 | Q3SY00 | |
| GGILSPLVKDRTSPS | 4516 | O75445 | |
| PKPARSSVAGSLSLR | 761 | O94972 | |
| LLLPSLLGATRASPT | 6 | Q6NUJ1 | |
| LPIPASKRASSDLSI | 331 | Q9H2G2 | |
| ETPPSRLTGLKRLSS | 1276 | Q8IWB6 | |
| PPGCAKTTLVRALAT | 506 | Q9BVQ7 | |
| RKLSPFVLSAGSGSP | 906 | Q9UMZ2 | |
| LGDKEISRSSPSPAL | 1076 | Q9UMZ2 | |
| LLSGKSPRKSAEPSA | 151 | Q13428 | |
| PSSGLVTLEKSPALA | 826 | O14513 | |
| PPSASALLGASIKLT | 26 | A0A075B6K6 | |
| PSKIGLLTSGTSRLE | 471 | Q5HYW2 | |
| LLQGLSKLSPSTSGP | 961 | Q9HCE1 | |
| LLRPAANVTPTKGSS | 881 | P0DJD1 | |
| PKLREPSKTALGSSL | 1251 | Q8IVL1 | |
| DAPTSLPKATRKALG | 51 | Q9NZH4 | |
| PRSALAPNLLTSGKK | 161 | O15446 | |
| LEGRKSSLPSVAPTG | 36 | Q7Z4S9 | |
| ARLEPLPLTSLKGSA | 101 | P0DH78 | |
| LPLTSLKGSAITRQP | 106 | P0DH78 | |
| GSRAALPLTKASPES | 491 | P81133 | |
| GILFVSSRKHLPTLP | 91 | Q5VXU9 | |
| GSASPKVPRTLLTLD | 311 | Q96FS4 | |
| TPSSPGKLLTRSLAL | 301 | Q96C36 | |
| PLVITRITPGSKAAA | 26 | Q53GG5 | |
| GAKLLRTLSSPTEPV | 221 | P40306 | |
| TKLPLLSRVPSAGSS | 471 | Q8IX21 | |
| LPSRQKTSLLASGAP | 411 | P20701 | |
| TELSPTATPRTLKLG | 311 | Q8NCF5 | |
| LVPGAKSSIGLSTIP | 4721 | Q8IVF2 | |
| SSPKLPVSSLGLAAS | 371 | Q99856 | |
| PKSSALPRTATLATL | 196 | Q96F05 | |
| TPTPSAGKRSLLISR | 116 | Q8IWZ8 | |
| PRKTLGPSDLSLLSL | 66 | Q9Y6X2 | |
| TSAAIPALPGSKGVL | 471 | Q9Y6X2 | |
| TPAPILSGKRKASTA | 376 | Q8IZ63 | |
| SPALSLSSAPTKPLL | 3096 | Q86UP3 | |
| GSPPSIADTLFSRKL | 141 | Q8WWQ0 | |
| ALLGPPRALSSLAAK | 36 | Q96AN5 | |
| PRLSPCSSIGKLSKS | 346 | Q13905 | |
| PPSALGLSTRKALSV | 11 | Q12767 | |
| GTSVRKTLLLCSPQP | 281 | Q9BSV6 | |
| ASIGNIALSPSPVRK | 141 | Q9BQI5 | |
| KRLLSDSLPPSTGTF | 1221 | Q9Y490 | |
| RTLAPLLASLLSPGS | 21 | P35270 | |
| LTPGRPAAGLSTCKT | 21 | P01137 | |
| RLSSASTGKPPLSVE | 756 | O75152 | |
| PPLSRSSVLKSALGP | 856 | Q12772 | |
| GPLRPKTLLLTSSEI | 1366 | Q9Y2I1 | |
| SRTDKLGSSILPPLT | 1861 | Q9H5I5 | |
| GSLRVKSPSKLAVNP | 296 | Q9HCK1 | |
| SKLTRAPDSPSSVGR | 206 | P28908 | |
| SAGSLTSLSLRGKPP | 1551 | Q92576 | |
| PSALGSRKLGPRSLS | 11 | O95685 | |
| SELSAPTRQKLPALG | 931 | O95359 | |
| LLSSKLERPSGGSKP | 1321 | Q2M1Z3 | |
| VATLGRSPSPKSALL | 996 | Q86UU1 | |
| PVTPSLADKLLSRLG | 526 | Q96GW9 | |
| DKGISVSLSLPSLPS | 126 | Q9UFV1 | |
| LSGTTLLPKLIPSGA | 16 | Q9UI14 | |
| RRLSSASTGKPPLSV | 756 | A0A1B0GTU1 | |
| ASRLGLSIPDLTPKQ | 181 | Q6PI78 | |
| SPASLARTLGSKSLL | 351 | Q96NM4 | |
| ARTLGSKSLLPGLSA | 356 | Q96NM4 | |
| EFIRATPSKPSGLSL | 141 | Q96NB3 | |
| TIRASLGPLQSKLPT | 511 | Q8ND82 | |
| KSPLALETPNRVSLG | 616 | Q5TAX3 | |
| SLASAISGKIPSPLS | 196 | Q14679 | |
| ASSLGSPLPRAKELI | 276 | Q04725 | |
| LAPGSKVPLSLRIAS | 736 | Q9Y334 | |
| GSIDPPSSLKSRLTG | 191 | Q7Z2V1 | |
| VSKPSAPVFDRLGSL | 76 | Q69YN4 | |
| LGASPRLKVSKPSLS | 1321 | Q68DK2 | |
| LGATRPTAPASAKRT | 96 | P50607 | |
| TSTPSALPTGEKALL | 716 | P15822 | |
| GLASSPRAPLQSSKA | 6 | Q3YBR2 | |
| KLQRPLTPGSSDSLT | 511 | O75962 | |
| SILSAASPGAKLPRV | 171 | Q6ZQT7 | |
| LLKFVTSCSRPPLLG | 1011 | Q15386 | |
| LKSRSSPSLLEPLLA | 16 | P57075 | |
| AEKSLPLPKSTSGSR | 271 | O75132 | |
| TLKGTPSSSAPLALV | 126 | E9PAV3 | |
| ASSKPPRISGSLVDT | 611 | Q9BTX1 | |
| RSISKKPLDIGLPSS | 1016 | Q13224 |